To discuss advancements in canaloplasty techniques for glaucoma treatment, particularly focusing on the use of implantable bioscaffolds to enhance Schlemm’s canal function and lower intraocular pressure (IOP).
Approach:
Key Findings:
Canaloplasty provides greater and more sustained IOP reduction compared to viscoelastic-only dilation, which lacks permanent reinforcement.
Ab interno canaloplasty techniques are gaining focus due to their favorable safety profiles and less invasive nature.
Recent meta-analysis supports the efficacy of canaloplasty with scaffolding, indicating a shift in surgical approaches.
Interpretation:
The evolution of canaloplasty techniques reflects a shift towards less invasive, more effective surgical options for managing glaucoma, with promising new materials and methods enhancing treatment outcomes.
Limitations:
Canaloplasty remains a low-volume procedure with relatively low utilization, which may limit patient access to this treatment option.
Further clinical studies are needed to establish long-term outcomes and efficacy of newer techniques.
Conclusion:
Advancements in canaloplasty techniques, particularly with implantable scaffolding, represent a significant addition to glaucoma surgical options, enhancing the potential for improved patient outcomes.
by John S. McInnes, MD, JD, Nathan M. Radcliffe, MD, Cynthia Mattox, MD, John S. McInnes, MD, JD, Nathan M. Radcliffe, MD, Cynthia Mattox, MD, John S. McInnes, MD, JD, Nathan M. Radcliffe, MD, Cynthia Mattox, MD
